Literature DB >> 11135622

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells.

K Takeda1, Y Hayakawa, M J Smyth, N Kayagaki, N Yamaguchi, S Kakuta, Y Iwakura, H Yagita, K Okumura.   

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various tumor cells in vitro, but its physiological role in tumor surveillance remains unknown. Here, we report that TRAIL is constitutively expressed on murine natural killer (NK) cells in the liver and plays a substantial role in suppressing tumor metastasis. Freshly isolated NK cells, but not natural killer T cells or ordinary T cells, from the liver expressed cell surface TRAIL, which was responsible for spontaneous cytotoxicity against TRAIL-sensitive tumor cells in vitro along with perforin and Fas ligand (FasL). Administration of neutralizing monoclonal antibody against TRAIL significantly increased experimental liver metastases of several TRAIL-sensitive tumor cell lines. Such an anti-metastatic effect of TRAIL was not observed in NK cell-depleted mice or interferon-gamma-deficient mice, the latter of which lacked TRAIL on liver NK cells. These findings provide the first evidence for the physiological function of TRAIL as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135622     DOI: 10.1038/83416

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  198 in total

1.  TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets.

Authors:  Stephanie C Heidemann; Valerie Chavez; Carol J Landers; Torsten Kucharzik; John L Prehn; Stephan R Targan
Journal:  J Clin Immunol       Date:  2010-03-27       Impact factor: 8.317

2.  Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression.

Authors:  Elena Strekalova; Dmitry Malin; David M Good; Vincent L Cryns
Journal:  Clin Cancer Res       Date:  2015-02-27       Impact factor: 12.531

3.  Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer.

Authors:  Wei Zhu; Hongwei Zhang; Yi Shi; Mangen Song; Bijun Zhu; Lai Wei
Journal:  Cancer Biol Ther       Date:  2013-08-28       Impact factor: 4.742

Review 4.  The role of natural killer cells in curbing neuroinflammation.

Authors:  Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2007-09-29       Impact factor: 3.478

5.  CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis.

Authors:  Bryan M Burt; George Plitas; Jennifer A Stableford; Hoang M Nguyen; Zubin M Bamboat; Venu G Pillarisetty; Ronald P DeMatteo
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

Review 6.  Death receptor signal transducers: nodes of coordination in immune signaling networks.

Authors:  Nicholas S Wilson; Vishva Dixit; Avi Ashkenazi
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

7.  Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Sophia Tseleni-Balafouta; Avi Ashkenazi; Demetrios A Koutras; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity.

Authors:  Valerie R Wiersma; Marco de Bruyn; Ce Shi; Marloes J M Gooden; Maartje C A Wouters; Douwe F Samplonius; Djoke Hendriks; Hans W Nijman; Yunwei Wei; Jin Zhou; Wijnand Helfrich; Edwin Bremer
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease.

Authors:  Kazuyoshi Takeda; Yuko Kojima; Kenichi Ikejima; Kenichi Harada; Shunhei Yamashina; Kyoko Okumura; Tomonori Aoyama; Steffen Frese; Hiroko Ikeda; Nicole M Haynes; Erika Cretney; Hideo Yagita; Noriyoshi Sueyoshi; Nobuhiro Sato; Yasuni Nakanuma; Mark J Smyth; Ko Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

10.  BH3-only protein bid participates in the Bcl-2 network in healthy liver cells.

Authors:  Hayato Hikita; Tetsuo Takehara; Takahiro Kodama; Satoshi Shimizu; Atsushi Hosui; Takuya Miyagi; Tomohide Tatsumi; Hisashi Ishida; Kazuyoshi Ohkawa; Wei Li; Tatsuya Kanto; Naoki Hiramatsu; Lothar Hennighausen; Xiao-Ming Yin; Norio Hayashi
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.